Amylyx Pharmaceuticals, Inc. AMLX 深 滬
等待開盤 08-21 09:30:00 美东时间
39.66
+1.060
+2.75%
華盛通- 最 高40.4388
- 今 開37.49
- 成交量 854.08万股
- 最 低 37.372
- 昨 收 38.60
- 總市值 44.19亿
- 52周最高 40.4388
- 市盈率 靜 --
- 換手率 7.67%
- 52周最低 9.145
- 委 比 52.67%
- 總股本 1.11亿
- 歷史最高 41.9297
- 量 比 1.19
- 振 幅 7.95%
- 歷史最低 1.575
- 每 手 1
- 風險率 3.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | 医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%
医药股AMLX飙升63%，全球首创GLP-1R拮抗剂三期临床试验成功；WEAV劲升31%，获私募巨头溢价34%收购；CDNL升逾15%，高管近日增持320万美元股份>>
08-19 16:11
Why Flexsteel Industries Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Shares of Flexsteel Industries Inc (NASDAQ:FLXS) rose sharply in pre-market trading as the company posted better-than-expected fourth-quarter financial results. The company reported quarterly earnings of $1.33 per share, which beat the analyst consensus estimate of $1.09 per share. The company repor...
08-18 17:01
美股大行评级 | 潜在涨幅455.56%！Cardiol Therapeutics获Canaccord Genuity上调目标价至10美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Cardiol Therapeutics"买入"评级，目标价从8美元升至10美元；B. Riley证券：维持Macrogenics"买入"评级，目标价从9美元升至11美元
08-18 11:39
Amylyx Pharmaceuticals Stock Soars After the Close: Here's Why
Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) shares are trading higher in Monday’s after-hours session after the company scheduled a Phase 3 trial results readout for this week. Amylyx Pharmaceuticals shares are testing new highs. What’s driving AMLX to record levels? Amylyx Pharma Announces Phase 3 LUC...
08-18 04:53
Mizuho Maintains Outperform on Amylyx Pharmaceuticals, Raises Price Target to $30
Mizuho analyst Graig Suvannavejh maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Outperform and raises the price target from $24 to $30.
08-17 19:27
美股大行评级 | 潜在涨幅3586.64%！HC Wainwright上调Enlivex目标价至80美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Enlivex"买入"评级，目标价从20美元升至80美元；Canaccord Genuity：维持Pharming Group NV Sponsored ADR"买入"评级，目标价从37美元升至38美元
08-04 11:45
Citigroup Maintains Buy on Amylyx Pharmaceuticals, Raises Price Target to $26
Citigroup analyst Geoff Meacham maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy and raises the price target from $20 to $26.
08-04 03:35
美股大行评级 | 伯恩斯坦上调Robinhood目标价从130美元升至160美元；纽约梅隆银行、Datadog、五三银行、旅行者财产险集团获多家机构上调评级
今日重点评级关注：Needham：维持Immuneering"买入"评级，目标价从11美元升至18美元；富瑞：维持塞德斯医疗"买入"评级，目标价从90美元升至100美元
07-21 11:36
Mizuho Maintains Outperform on Amylyx Pharmaceuticals, Raises Price Target to $24
Mizuho analyst Graig Suvannavejh maintains Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Outperform and raises the price target from $21 to $24.
07-20 19:34
美股大行评级 | 潜在涨幅135.66%！Ocular Therapeutix获Chardan Capital升目标价至23美元，维持"买入"评级
今日重点评级关注：Chardan Capital：维持Ocular Therapeutix"买入"评级，目标价从21美元升至23美元；Guggenheim：维持Amylyx Pharmaceuticals"买入"评级，目标价从30美元升至40美元
06-26 17:42
